Technologies.Author Contributions: Conceptualization, D.O.I., L.B., and V.I.B.; formal analysis, D.M.K.; investigation, D.M.K., S.X., and M.P.M.; methodology, S.X. and M.P.M.; project administration, L.B. and V.I.B.; supervision, D.O.I., L.B., and V.I.B.; PF-06454589 web writing–original draft, D.M.K., S.X., D.O.I., L.B., and V.I.B.; writing–review and editing, D.M.K., D.O.I., L.B., and V.I.B. All authors have read and agreed towards the published version in the manuscript.Nanomaterials 2021, 11,7 ofFunding: This study was funded by the Ministry of Science and Higher Education of Russian Federation, Megagrant project N 0755019934. S.X. and L.B. are grateful for help from the National Organic Science Foundation of China (NSFC) (grant Nos. 51972044 and 52021001), Ministry of Science and Technologies from the People’s Republic of China (MOST) (grant Nos. 2016YFA0300802 and 2018YFE0109200), Sichuan Provincial Science and Technology Division (grant Nos. 2019YFH0154 and 2020ZYD015). Institutional Evaluation Board Statement: Not applicable. Informed Consent Statement: Not applicable. Data Availability Statement: The information presented within this study are accessible on request in the corresponding author. Conflicts of Interest: The authors declare no conflict of interest.Appendix A. Optical Properties of Ce:DyIGFigure A1. Dielectric permittivity (a) and gyration (b) of Ce:DyIG.Appendix B. Electromagnetic Field Distribution from the TM1 and TE1 ModesFigure A2. Electromagnetic field distribution of your TM1(, 0) (a,c) and TE1(0, ) (b,d) modes.Nanomaterials 2021, 11,eight ofAppendix C. Numerically Calculated Angle-Resolved TMOKE SpectraFigure A3. Numerically simulated TMOKE spectra as a function of (a) and for fixed = ten as a function of your sample rotation angle (b). All curves in (b) have offsets to clarify representation.Appendix D. Schematic of TMOKE SetupFigure A4. Schematic of TMOKE setup employed in the experiment.
nanomaterialsReviewThe Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria towards the Treatment of Solid TumorsKyle M. Pierce 1 , William R. Miklavcic two , Kyle P. Cook 1 , Mikayla Sweitzer Hennen 1 , Kenneth W. Bayles 3 , Michael A. Hollingsworth 2 , Amanda E. Brooks 4 , Jessica E. Pullan four, and Kaitlin M. Dailey two, ,Biomedical Sciences, Rocky Vista University, JPH203 site Parker, CO 80130, USA; [email protected] (K.M.P.); [email protected] (K.P.C.); [email protected] (M.S.H.) Eppley Institute for Cancer Research, University of Nebraska Healthcare Center, Omaha, NE 68198, USA; [email protected] (W.R.M.); [email protected] (M.A.H.) Division of Pathology and Microbiology, University of Nebraska Health-related Center, Omaha, NE 68198, USA; [email protected] Workplace of Investigation Scholarly Activity, Rocky Vista University, Ivins, UT 84738, USA; [email protected] (A.E.B.); [email protected] (J.E.P.) Correspondence: [email protected] These authors contributed equally to this function.Citation: Pierce, K.M.; Miklavcic, W.R.; Cook, K.P.; Hennen, M.S.; Bayles, K.W.; Hollingsworth, M.A.; Brooks, A.E.; Pullan, J.E.; Dailey, K.M. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria towards the Treatment of Strong Tumors. Nanomaterials 2021, 11, 3018. https://doi.org/10.3390/nano11113018 Academic Editors: Pablo Botella and Christopher C. LandryAbstract: Though several classes of chemotherapeutic agents exist to treat solid tumors, handful of can create a lasting response with no.